MEI Pharma Inc. (MEIP)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

2.70

1.89%

After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07	FY06	FY05	FY04	FY03	FY02
Revenue	65.30M	48.82M	40.70M	25.54M	28.91M	4.92M	1.62M	23.25M	-	-	-	-	-	-	84.00K	228.00K	674.00K	645.00K	-120.00K	308.00K	193.00K	145.00K	7.00K
Cost of Revenue	383.00K	1.81M	1.24M	1.41M	2.67M	4.26M	3.38M	5.00M	58.00K	-	-	-	-	-	-	-	-	-	-	-	-	500.00K	-
Gross Profit	64.91M	47.00M	39.46M	24.13M	26.24M	652.00K	-1.76M	18.25M	-58.00K	-	-	-	-	-	84.00K	228.00K	674.00K	645.00K	-120.00K	308.00K	193.00K	-355.00K	7.00K
Operating Income	14.54M	-36.76M	-75.48M	-69.69M	-24.54M	-46.24M	-28.59M	2.38M	-21.00M	-32.77M	-27.23M	-11.22M	-8.39M	-6.45M	-7.89M	-11.18M	-13.08M	-13.82M	-7.38M	-6.42M	-8.54M	-3.03M	-122.00K
Interest Income	3.28M	3.35M	284.00K	510.00K	1.40M	1.79M	591.00K	287.00K	143.00K	78.00K	81.00K	37.00K	39.00K	130.00K	84.00K	228.00K	-	-	-	-	-	-	-
Pretax Income	17.78M	-31.84M	-54.45M	-50.57M	-46.02M	-16.82M	-40.07M	2.67M	-20.86M	-32.69M	-27.15M	-11.19M	-7.52M	-6.78M	-7.89M	-11.18M	-12.41M	-13.82M	-7.38M	-6.42M	-8.54M	-3.03M	-122.00K
Net Income	17.78M	-31.84M	-54.45M	-41.31M	-47.17M	-16.82M	-40.07M	2.67M	-20.86M	-32.69M	-27.15M	-11.19M	-7.52M	-6.78M	-7.90M	-11.18M	-12.41M	-13.82M	-7.39M	-6.42M	-8.54M	-3.03M	-123.00K
Selling & General & Admin	23.30M	33.13M	30.54M	24.41M	16.72M	14.60M	9.79M	8.63M	5.67M	7.17M	6.45M	5.14M	3.48M	4.34M	3.95M	3.63M	3.76M	8.70M	4.40M	4.45M	6.35M	654.00K	-
Research & Development	16.56M	52.45M	85.64M	69.40M	34.06M	32.30M	17.04M	7.24M	13.40M	23.82M	19.33M	6.08M	4.92M	2.12M	4.03M	7.78M	9.32M	5.76M	3.43M	2.28M	2.38M	2.02M	-
Other Expenses	10.90M	-22.00K	-6.00K	486.00K	-	-	15.42M	4.87M	1.93M	1.77M	1.45M	-	3.48M	4.34M	3.95M	3.63M	4.43M	8.70M	3.96M	4.45M	6.35M	654.00K	129.00K
Operating Expenses	50.76M	85.58M	116.18M	93.81M	50.78M	46.90M	26.82M	15.87M	21.00M	32.77M	27.23M	11.22M	8.39M	6.45M	7.98M	11.41M	13.76M	14.46M	7.38M	6.73M	8.73M	2.68M	129.00K
Interest Expense	-	-	284.00K	-	-	-	2.37M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.21M	-	-	-	-	-
Cost & Expenses	50.76M	85.58M	116.18M	95.22M	53.45M	51.16M	30.21M	20.86M	21.00M	32.77M	27.23M	11.22M	8.39M	6.45M	7.98M	11.41M	13.76M	14.46M	7.38M	6.73M	8.73M	3.18M	129.00K
Income Tax	-	-4.95M	284.00K	8.00K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	1K	3.00K	1K	1K	-	-	-	1K
Shares Outstanding (Basic)	6.66M	6.66M	6.22M	5.63M	4.55M	3.56M	2.07M	1.85M	1.71M	1.41M	1.00M	508.04K	112.39K	63.70K	61.22K	60.89K	56.92K	52.66K	47.45K	47.45K	45.80K	43.35K	41.47K
Shares Outstanding (Diluted)	6.66M	6.66M	6.26M	5.72M	4.55M	3.62M	2.07M	1.91M	1.72M	1.41M	1.00M	508.04K	112.39K	63.70K	61.22K	60.89K	56.92K	52.66K	47.45K	47.45K	45.80K	43.35K	41.47K
EPS (Basic)	2.67	-4.78	-8.75	-7.4	-10.4	-4.73	-19.34	1.40	-12.2	-23.2	-27.06	-22.02	-66.94	-106.46	-128.98	-183.6	-218.03	-262.42	-155.67	-135.33	-186.44	-69.96	-2.97
EPS (Diluted)	2.67	-4.78	-9.99	-12	-10.4	-4.65	-19.34	1.45	-12.13	-23.18	-27.06	-22.02	-66.94	-106.46	-128.98	-183.6	-218.03	-262.42	-155.67	-135.33	-186.44	-69.96	-2.97
EBITDA	26.38M	-36.76M	-75.16M	-60.14M	-25.59M	-46.16M	-28.53M	2.47M	-20.95M	-32.71M	-27.18M	-11.18M	-7.10M	-6.77M	-7.89M	-11.18M	-13.08M	-13.82M	-7.38M	-6.42M	-8.54M	-3.03M	-122.00K
Depreciation & Amortization	383.00K	1.81M	1.24M	285.00K	109.00K	80.00K	53.00K	85.00K	58.00K	64.00K	50.00K	45.00K	13.00K	13.00K	-	-	-	-	-	-	-	-	-